JP2024518375A5 - - Google Patents
Info
- Publication number
- JP2024518375A5 JP2024518375A5 JP2023567891A JP2023567891A JP2024518375A5 JP 2024518375 A5 JP2024518375 A5 JP 2024518375A5 JP 2023567891 A JP2023567891 A JP 2023567891A JP 2023567891 A JP2023567891 A JP 2023567891A JP 2024518375 A5 JP2024518375 A5 JP 2024518375A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- lipid
- acceptable salt
- compound
- lipid composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163185303P | 2021-05-06 | 2021-05-06 | |
| US63/185,303 | 2021-05-06 | ||
| PCT/US2022/027874 WO2022235935A2 (en) | 2021-05-06 | 2022-05-05 | Ionizable cationic lipids for rna delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024518375A JP2024518375A (ja) | 2024-05-01 |
| JP2024518375A5 true JP2024518375A5 (cg-RX-API-DMAC10.html) | 2025-05-13 |
Family
ID=83932495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023567891A Pending JP2024518375A (ja) | 2021-05-06 | 2022-05-05 | Rna送達のためのイオン化可能なカチオン性脂質 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220389422A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4352038A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024518375A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240008872A (cg-RX-API-DMAC10.html) |
| CN (2) | CN121517316A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022268975A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3219192A1 (cg-RX-API-DMAC10.html) |
| TW (1) | TW202313557A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022235935A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10526284B2 (en) | 2016-12-21 | 2020-01-07 | Arcturus Therapeutics, Inc. | Ionizable cationic lipid for RNA delivery |
| US10383952B2 (en) | 2016-12-21 | 2019-08-20 | Arcturus Therapeutics, Inc. | Ionizable cationic lipid for RNA delivery |
| CN117098541A (zh) | 2020-11-25 | 2023-11-21 | 阿卡格拉医药公司 | 用于递送核酸的脂质纳米粒及相关使用方法 |
| AU2023379598A1 (en) * | 2022-11-16 | 2025-05-08 | Seawolf Therapeutics, Inc. | Ionizable lipids and lipid nanoparticle compositions for the delivery of nucleic acids |
| WO2024192528A1 (en) * | 2023-03-22 | 2024-09-26 | Nanovation Therapeutics Inc. | Ionizable anionic lipids |
| WO2024233750A1 (en) * | 2023-05-10 | 2024-11-14 | Arcturus Therapeutics, Inc. | Ionizable cationic lipids for rna delivery |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| CN117482066B (zh) * | 2023-11-02 | 2024-08-13 | 深圳市易瑞生物技术股份有限公司 | 脂质组合物和用于脂质组合物的化合物 |
| WO2025117732A1 (en) * | 2023-11-29 | 2025-06-05 | Akagera Medicines, Inc. | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof |
| IL328626A (en) | 2023-12-15 | 2026-07-01 | Capstan Therapeutics Inc | Humanized anti-CD8 antibodies and their uses |
| WO2025134071A1 (en) * | 2023-12-22 | 2025-06-26 | Sanofi | Malic and glutaric acid based ionizable lipids |
| CN117820149B (zh) * | 2023-12-29 | 2025-01-07 | 北京剂泰医药科技有限公司 | 可电离脂质化合物 |
| WO2025140421A1 (zh) * | 2023-12-29 | 2025-07-03 | 北京剂泰医药科技有限公司 | 可电离脂质化合物及其在递送核酸疫苗中的用途 |
| AU2025217182A1 (en) | 2024-02-02 | 2026-08-06 | Editas Medicine, Inc. | MODIFIED GUIDE RNAs |
| WO2025213138A1 (en) | 2024-04-05 | 2025-10-09 | Editas Medicine, Inc. | Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| CN121021427A (zh) * | 2024-07-30 | 2025-11-28 | 广州市恒诺康医药科技有限公司 | 可离子化脂质及其用途 |
| WO2026102260A1 (en) | 2024-11-08 | 2026-05-15 | Editas Medicine, Inc. | Crispr-related methods and compositions targeting angiopoietin like 3 (angptl3) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2350296A4 (en) * | 2008-11-17 | 2013-04-03 | Enzon Pharmaceuticals Inc | BRANCHED CATIONIC LIPIDS FOR THE SYSTEM FOR INTRODUCING NUCLEIC ACIDS |
| CA2853689C (en) * | 2011-11-04 | 2020-06-30 | Nitto Denko Corporation | Method of producing lipid nanoparticles for drug delivery |
| DE21212055T1 (de) * | 2011-12-07 | 2022-08-04 | Alnylam Pharmaceuticals, Inc. | Biologisch abbaubare lipide zur freisetzung von wirkstoffen |
| WO2013086322A1 (en) * | 2011-12-07 | 2013-06-13 | Alnylam Pharmaceuticals, Inc. | Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents |
| AU2013355258A1 (en) * | 2012-12-07 | 2015-06-11 | Alnylam Pharmaceuticals, Inc. | Improved nucleic acid lipid particle formulations |
| WO2015011633A1 (en) * | 2013-07-23 | 2015-01-29 | Protiva Biotherapeutics, Inc. | Compositions and methods for delivering messenger rna |
| US10383952B2 (en) * | 2016-12-21 | 2019-08-20 | Arcturus Therapeutics, Inc. | Ionizable cationic lipid for RNA delivery |
| JP7436990B2 (ja) * | 2018-08-10 | 2024-02-22 | 国立大学法人京都大学 | カチオン性脂質を用いた心筋細胞へのトランスフェクション方法 |
| PL3908568T3 (pl) * | 2019-01-11 | 2024-12-02 | Acuitas Therapeutics, Inc. | Lipidy do dostarczania środków czynnych w nanocząstkach lipidowych |
| EP3942050A4 (en) * | 2019-03-19 | 2023-02-22 | Arcturus Therapeutics, Inc. | PROCEDURE FOR THE PRODUCTION OF LIPID-COATED RNA NANOPARTICLES |
| GB2600859B (en) * | 2019-08-14 | 2024-04-03 | Acuitas Therapeutics Inc | Improved lipid nanoparticles for delivery of nucleic acids |
-
2022
- 2022-05-05 CN CN202511412284.XA patent/CN121517316A/zh active Pending
- 2022-05-05 CN CN202280043621.0A patent/CN117715886B/zh active Active
- 2022-05-05 WO PCT/US2022/027874 patent/WO2022235935A2/en not_active Ceased
- 2022-05-05 EP EP22799597.4A patent/EP4352038A4/en active Pending
- 2022-05-05 CA CA3219192A patent/CA3219192A1/en active Pending
- 2022-05-05 TW TW111116949A patent/TW202313557A/zh unknown
- 2022-05-05 US US17/737,690 patent/US20220389422A1/en active Pending
- 2022-05-05 KR KR1020237041979A patent/KR20240008872A/ko active Pending
- 2022-05-05 AU AU2022268975A patent/AU2022268975A1/en active Pending
- 2022-05-05 JP JP2023567891A patent/JP2024518375A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024546431A5 (cg-RX-API-DMAC10.html) | ||
| JP5095708B2 (ja) | 核酸様化合物の送達 | |
| CA2622584C (en) | Improvements in or relating to amphoteric liposomes | |
| US7341738B2 (en) | Lipid-encapsulated polyanionic nucleic acid | |
| JP4203835B2 (ja) | 全身への送達を増加させる新規のリポソーム複合体 | |
| EP3628335B1 (en) | Lipidic nanoparticles for mrna delivery in the lungs | |
| JP4951338B2 (ja) | 脂質に封入された干渉rna | |
| JP7595984B2 (ja) | 脂質ナノ粒子 | |
| JP2022530018A5 (cg-RX-API-DMAC10.html) | ||
| JP2017536092A5 (cg-RX-API-DMAC10.html) | ||
| CN115515559B (zh) | 信使rna的直肠递送 | |
| JP2003535832A (ja) | ポリヌクレオチドおよび薬物の標的化リポソームへのカプセル化 | |
| TW201717914A (zh) | 用於奈米顆粒冷凍乾燥形式的組成物及方法 | |
| KR100723852B1 (ko) | 핵산 및 약물 전달용 중성-양이온성 지질 | |
| CA2223928A1 (en) | Cationic lipid:dna complexes for gene targeting | |
| Oku et al. | Evaluation of drug targeting strategies and liposomal trafficking. | |
| US6897200B1 (en) | Oligonucleotide delivery systems for camptothecins | |
| JP2023513302A (ja) | 治療的に活性な作用物質を内皮へと送達するための脂質組成物およびその使用 | |
| CN120835876A (zh) | 包括具有支化结构的电离脂质的脂质纳米粒制剂及其用途 | |
| Maclean et al. | Immunoliposomes as targeted delivery vehicles for cancer therapeutics | |
| CN113403313A (zh) | 一种特异识别人PLK1位点的sgRNA、质粒、纳米复合物和应用 | |
| JP6384863B2 (ja) | 脂質膜構造体 | |
| US20230301913A1 (en) | Silyl lipids suitable for enhanced delivery of anti-viral therapeutics | |
| HK40060954A (en) | Lipid nanoparticle | |
| CN120241640A (zh) | 靶向纳米粒组合物及其应用 |